4//SEC Filing
Janda Kim 4
Accession 0001209191-21-026867
CIK 0000850261other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 6:43 PM ET
Size
9.0 KB
Accession
0001209191-21-026867
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Exercise/Conversion
Common Stock
2021-04-12$3.50/sh+1,900$6,650→ 4,900 total - Exercise/Conversion
Non-qualified stock option
2021-04-12−1,900→ 0 totalExercise: $3.50From: 2012-04-15Exp: 2021-04-15→ Common Stock (1,900 underlying) - Sale
Common Stock
2021-04-12$6.97/sh−1,900$13,251→ 3,000 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 22, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001518466
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 6:43 PM ET
- Size
- 9.0 KB